Associate Director, HEOR
- Employer
- CSL
- Location
- King of Prussia, PA
- Start date
- Jan 13, 2025
View more categoriesView less categories
- Discipline
- Clinical, Health Economics & Outcomes Research
- Required Education
- Masters Degree/MBA
- Position Type
- Full time
- Hotbed
- Pharm Country, Best Places to Work
Job Details
The Associate Director of Health Economics and Outcomes Research (HEOR) will be leading the development and execution of HEOR strategies for CSL Behring or Vifor assets primarily within a specific disease area. This role focuses on leading the plan, execution and dissemination of the payer evidence generation to maximize the asset's value throughout its life cycle by securing and optimizing product pricing and reimbursement.
The position requires deep expertise in Health Economics, Real-World Evidence (RWE), and Health Technology Assessment (HTA) and a hands-on approach to executing HTA submissions and RWE studies.
In this position you will be directly reporting to the Executive Director HEOR, Market Access.
Potential locations: Switzerland (Zurich) or USA (King of Prussia).
Key Responsibilities:
Lead development, oversight, and execution of comprehensive and effective HEOR strategies demonstrating the value of CSL’s products to enable fast and optimal access worldwide.
Plan, execute and disseminate global value evidence generation studies and tools, such us Burden of Illness studies, Patient Preference and Patient Report Outcomes studies, Systematic Literature Reviews, Indirect Treatment Comparisons, Global Value Dossier, economic models, practical HEOR tools for payer engagement etc.
Engage with the Access Leads and Product Strategy Teams to facilitate early and appropriate evidence generation in pivotal trials, identify gaps, and shape mitigation strategies for worldwide HTA’s.
Support Access leads in planning and conducting Early Scientific Advice with key P&R and HTA agencies.
Shape pivotal trial design to adequately reflect payer evidence requirements, especially PICO (population, intervention, comparator, outcomes), devise mitigation strategies early on.
Collaborate with Medical Affairs, Epidemiology, Biostatistics and other relevant functions to develop and execute integrated evidence generation plans, driving value evidence needs definition, execution and compliant dissemination/communication based on the strategic objectives of the brand plan.
Lead cross-functional team to prepare EU JCA dossier and JSC/payer consultations, ensuring cross-functional alignment and seamless execution.
Support and ensure governance of local HTA submissions, adapting global HEOR value dossiers, health economic models and tools and anticipating evidence needs.
Ensure HEOR initiatives are aligned with the business needs and adequately funded.
Foster the collaboration with KOLs and internal and external partners to introduce innovative approaches and methods and validate the HEOR strategy.
Support the shaping and sharing of internal processes, procedures, approaches and best practices to elevate HEOR effectiveness.
Educate stakeholders on HTA and value evidence key requirements and developments.
Qualifications:
Experience: At least 8 years of experience in HEOR/market access, with significant exposure to healthcare systems in international markets.
Excellent analytical skills with experience in statistical modeling, data analysis, and interpretation of research findings.
Track Record: Demonstrated success in developing and executing HEOR and HTA strategies to secure and optimize pricing, reimbursement, and patient access.
Knowledge: Extensive understanding of HTA and benefit assessment processes and dynamics in key international markets.
Collaboration: Proven ability to work effectively in cross-functional teams, with strong communication and influencing skills.
Education: An advanced degree in Health Economics, Public Health, or a related field is required.
Are you interested in this exciting opportunity? We are looking forward to receiving your online application.
About CSL ViforCSL Vifor aims to become the global leader in iron deficiency and nephrology.
The company is a partner of choice for pharmaceuticals and innovative patient-focused solutions across iron, dialysis, nephrology and rare conditions. CSL Vifor strives to help patients around the world with severe, chronic and rare diseases lead better, healthier lives. It specializes in strategic global partnering, in-licensing and developing, manufacturing and marketing pharmaceutical products for precision patient care.
For more information, please visit viforpharma.com
We want CSL to reflect the world around usAs a global organization with employees in 35+ countries, CSL embraces diversity and inclusion. Learn more about Diversity & Inclusion at CSL.
Do work that matters at CSL Vifor!Company
CSL is a global biotechnology company with a dynamic portfolio of lifesaving medicines, including those that treat hemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency and nephrology. Since our start in 1916, we have been driven by our promise to save lives using the latest technologies. Today, CSL – including our three businesses, CSL Behring, CSL Seqirus and CSL Vifor – provides lifesaving products to patients in more than 100 countries and employs 32,000 people.
Areas of Expertise
We focus and demonstrate global leadership in three distinct areas—rare and serious diseases; influenza vaccines; and iron deficiency and nephrology.
Rare & Serious Diseases
CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients' needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas.
Vaccines
As one of the largest influenza vaccine providers in the world, CSL Seqirus is a major contributor to the prevention of influenza globally and a transcontinental partner in pandemic preparedness. CSL Seqirus utilizes egg, cell and adjuvant technologies to offer a broad portfolio of differentiated influenza vaccines in more than 20 countries.
Iron Deficiency & Nephrology
With our iron deficiency and iron deficiency anemia expertise in heart failure, kidney disease, gastroenterology or inflammatory bowel disease, patient blood management and women’s health, we help patients affected by these conditions to live better, healthier lives.
- Phone
- 610-878-4000
- Location
-
1020 First Avenue
King of Prussia
Pennsylvania
19406
United States
Get job alerts
Create a job alert and receive personalized job recommendations straight to your inbox.
Create alert